:
All

Product Name

Product Keyword

Product Model

Product Summary

Product Description

Multi Field Search
About

Organization

Our Team

Research & Development

Quality Control

Cost Control

Service

Formulation

API

Intermediate

Product

Pipelines in ATC Coding

Human Pharma API

Human Pharma Intermediates

Excipients

Tool Molecules

Cinchona Alkaloids

Halogen Introduction

Molecular Building Blocks

Roche Esters

Veterinary

Unibest Imports

Blogs

ESG

Partnership

Group Site

Join Us
CONTACT

Product Detail

All
Product Name
Product Keyword
Product Model
Product Summary
Product Description
Multi Field Search

CAS No.157322-83-3, methyl 2-（(2R,4aS,6S,7R.8S,8aS)-7 ,8-bis((tert-butyldimethylsilyl)oxy)-6-(-,E)-((tert-butyldimethyIsilyl)oxy)-3-iodallyI)octahydropyrano[3,2-b]pyran- 2 yl)acetate

CAS No.157322-83-3, methyl 2-（(2R,4aS,6S,7R.8S,8aS)-7 ,8-bis((tert-butyldimethylsilyl)oxy)-6-(-,E)-((tert-butyldimethyIsilyl)oxy)-3-iodallyI)octahydropyrano[3,2-b]pyran- 2 yl)acetate

Share to:

CAS No.157322-83-3, methyl 2-（(2R,4aS,6S,7R.8S,8aS)-7 ,8-bis((tert-butyldimethylsilyl)oxy)-6-(-,E)-((tert-butyldimethyIsilyl)oxy)-3-iodallyI)octahydropyrano[3,2-b]pyran- 2 yl)acetate

CAS No.:
157322-83-3
Molecular Formula:
C32H63IO7Si3
Molecular weight (g/mol):
771.009
Density (g/ml):
N/A
Melting Point (°C):
N/A
Flash Point (°C):
N/A
Physical Properties:
N/A
Indications:
L (Breast cancer; sarcoma; liposarcoma)
API Name:
Eribulin
Last Drug Patent Expires:
7/8/2027 (Eribulin)

Availability:



Inquire

Synthetic Roadmap

Eribulin-1-1~12 Eribulin-2-13~18 Eribulin-7-46~58 Eribulin-8-55~66 Eribulin-9-67~37

Are also in this series, click those CAS No. above

To check details

Illustrate

For the synthesis of Eribulin, Eribulin belongs to a new type of drug for the treatment of breast cancer. We offer high purity, kilogram production.

Download

Previous:

Next:

CAS No.157322-83-3